-
Professor Xuepei Zhang Shares Robotic Urologic Surgery Experience from the First Affiliated Hospital of Zhengzhou University
The 2025 Annual Meeting of the Chinese Urological Association (CUDA) was held from June 12–15 in the romantic city of Zhuhai. With the theme “Healthy China, Urology in Action,” the conference brought together experts from across the country to share the latest insights and practical experience in urologic surgery. At the conference, Professor Xuepei Zhang…
-
Professor Linhui Wang: The “Changhai Experience” in Clinical Research and Practice of Urologic Oncology | CUDA 2025
The 2025 Annual Meeting of the Chinese Urological Doctors Association (CUDA) was successfully held from June 12 to 15 in the romantic city of Zhuhai. With the theme “Healthy China, Urology in Action,” the conference gathered urological professionals from across the country to share cutting-edge knowledge and practical experience in the field. Professor Linhui Wang…
-
Highlights of ISEH 2025: Preview of China-Japan Joint Workshop on Stem Cells and Cell Therapy
The 54th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH 2025) will be held in Kumamoto, Japan, from September 24 to 27, 2025. One of the major…
-
2025 Advances from Dr. Husam Abu Jazar and the KHCC Team
In 2025, Dr. Husam Abu Jazar and colleagues at King Hussein Cancer Center published two impactful studies that could shape transplant care moving forward. The first study analyzed outcomes from…
-
Genome Engineering in Cancer Therapy: A New Era of Precision
The therapeutic landscape in oncology is undergoing a profound shift with the rise of genome engineering technologies such as CRISPR/Cas9, base editing, and prime editing. These tools are enabling the…
-
2025 ICML | Professor Shunan Qi on Risk-Adapted Radiotherapy Strategies for Early-Stage NK/T-Cell Lymphoma
Oncology Frontier – Hematology Frontier: Professor Qi, you have extensive experience in lymphoma radiotherapy. With the integration of modern systemic therapies in early-stage lymphoma, how has this affected the planning…
-
Voices from China in Lugano | Showcasing the Power of Chinese Solutions: Prof. Qingqing Cai’s Team Presents P-GEMOX + PD-1 and L-CHOP Regimens at ICML
Current Systemic Strategies and Emerging Therapies in ENKTCL Oncology Frontier – Hematology Frontier: What are the current frontline systemic therapies for ENKTCL in China and abroad? How do these treatments…
-
2025 ICML | Professor Jun Zhu: China–Europe Synergy Sparks a New Era — Advancing Global Collaboration in Lymphoma Research
Oncology Frontier – Hematology Frontier invited Professor Jun Zhu of Peking University Cancer Hospital to provide expert insights into the latest developments in China–Europe collaborative lymphoma research and to share…
Connecting Medical Expertise through Media